It’s an indubitable fact that the US sits at the top of the Biopharma industry. For the US, there is no limit to the innovation, discovery, or outsourcing of manufacturing and research facilities with their next-generation flexible manufacturing offered by numerous CDMOs and CROs. In 2023, the US government allocated 16.5 % of its GDP to healthcare. On the PharmaShots’ Top 20 Countries in Health Innovation, the United States ranked first on the list, scoring the highest amongst the competing countries.
In November, PharmaShots chose the US Healthcare as a theme to explore the nature of the healthcare ecosystem in the country. The magazine unearths the nuances of the US healthcare system, the kind of healthcare plans, the trends, recent regulatory updates, and much more through illuminating articles, illustrative infographics, engaging Bio Trends, enlightening regulatory updates, and a few interesting facts to keep you hooked throughout the magazine.
In December, PharmaShots will be exploring the European Healthcare System as a theme, and for the January 2025 Edition, the theme remains “Understanding China’s Healthcare”.
Get a chance to advertise with us for free! Share your promotional pieces, white papers, and interviews on connect@pharmashots.com
